Lgl Partners, LLC Gamida Cell Ltd. Transaction History

Lgl Partners, LLC

  • $634 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 03, 2021
SELL
$4.07 - $11.0 $54,945 - $148,500
-13,500 Closed
0 $0
Q2 2020

Aug 10, 2020
BUY
$2.79 - $6.5 $37,665 - $87,750
13,500 New
13,500 $62,000

Others Institutions Holding GMDA

# of Institutions
1
Shares Held
2.2K
Call Options Held
0
Put Options Held
0
View Full List

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Lgl Partners, LLC Portfolio

Follow Lgl Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgl Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lgl Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email